Janus Capital Management LLC cut its position in LifePoint Health Inc (NASDAQ:LPNT) by 70.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,500 shares of the company’s stock after selling 27,100 shares during the period. Janus Capital Management LLC’s holdings in LifePoint Health were worth $653,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Victory Capital Management Inc. increased its stake in LifePoint Health by 65.2% in the third quarter. Victory Capital Management Inc. now owns 1,692 shares of the company’s stock worth $100,000 after buying an additional 668 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in shares of LifePoint Health by 1,006.8% in the third quarter. Tower Research Capital LLC TRC now owns 2,756 shares of the company’s stock worth $163,000 after buying an additional 2,507 shares during the period. ETRADE Capital Management LLC bought a new position in shares of LifePoint Health during the third quarter worth approximately $257,000. Eqis Capital Management Inc. bought a new position in shares of LifePoint Health during the third quarter worth approximately $299,000. Finally, First Citizens Bank & Trust Co. boosted its position in shares of LifePoint Health by 1.7% in the third quarter. First Citizens Bank & Trust Co. now owns 5,233 shares of the company’s stock worth $310,000 after buying an additional 88 shares during the period. 99.88% of the stock is currently owned by institutional investors and hedge funds.
LifePoint Health Inc (NASDAQ:LPNT) opened at 60.85 on Tuesday. The company’s 50-day moving average price is $62.56 and its 200-day moving average price is $59.29. LifePoint Health Inc has a 12-month low of $50.60 and a 12-month high of $75.70. The stock has a market cap of $2.43 billion, a PE ratio of 21.58 and a beta of 0.87.
LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Friday, February 17th. The company reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.02. LifePoint Health had a return on equity of 7.02% and a net margin of 1.93%. The business earned $1.61 billion during the quarter, compared to analysts’ expectations of $1.63 billion. During the same quarter in the prior year, the firm earned $1.11 earnings per share. The business’s revenue was up 17.1% compared to the same quarter last year. On average, equities analysts expect that LifePoint Health Inc will post $4.18 EPS for the current fiscal year.
Your IP Address:
A number of equities analysts have recently commented on LPNT shares. Mizuho lifted their target price on LifePoint Health from $50.00 to $57.00 and gave the stock a “neutral” rating in a report on Tuesday, February 21st. Zacks Investment Research upgraded LifePoint Health from a “hold” rating to a “buy” rating and set a $62.00 target price for the company in a report on Wednesday, November 30th. TheStreet upgraded LifePoint Health from a “c+” rating to a “b-” rating in a report on Monday, March 13th. Piper Jaffray Companies started coverage on LifePoint Health in a report on Wednesday, January 4th. They issued a “neutral” rating and a $62.00 target price for the company. Finally, Cantor Fitzgerald reiterated a “neutral” rating on shares of LifePoint Health in a report on Tuesday, February 21st. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the stock. LifePoint Health currently has an average rating of “Hold” and an average target price of $65.30.
In other LifePoint Health news, insider David M. Dill sold 18,800 shares of the stock in a transaction that occurred on Thursday, March 16th. The stock was sold at an average price of $62.22, for a total transaction of $1,169,736.00. Following the completion of the transaction, the insider now owns 207,873 shares of the company’s stock, valued at $12,933,858.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP John P. Bumpus sold 26,362 shares of the stock in a transaction that occurred on Thursday, March 9th. The shares were sold at an average price of $65.05, for a total value of $1,714,848.10. Following the transaction, the executive vice president now directly owns 117,458 shares of the company’s stock, valued at approximately $7,640,642.90. The disclosure for this sale can be found here. Insiders have sold 46,667 shares of company stock valued at $2,982,409 in the last three months. Insiders own 7.28% of the company’s stock.
About LifePoint Health
LifePoint Health, Inc, formerly LifePoint Hospitals, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The Company operates through healthcare services segment. The Company operates over 70 hospital campuses in over 20 states, having a total of over 8,240 licensed beds.
Want to see what other hedge funds are holding LPNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifePoint Health Inc (NASDAQ:LPNT).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2024741/janus-capital-management-llc-cuts-stake-in-lifepoint-health-inc-lpnt.html
Receive News & Ratings for LifePoint Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.